{
  "drug_name": "Droperidol",
  "url": "https://wikem.org/wiki/Droperidol",
  "scraped_at": "2026-01-10T07:52:12.582097",
  "sections": {
    "Administration": {
      "text": "Type:\nantipsychotic\n,\nantiemetics\nDosage Forms: 5mg/2mL\nRoutes of Administration: IV/IM\nCommon Trade Names: Inapsine",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "antipsychotic",
          "url": "https://wikem.org/wiki/Antipsychotic"
        },
        {
          "text": "antiemetics",
          "url": "https://wikem.org/wiki/Antiemetics"
        }
      ]
    },
    "Adult_Dosing": {
      "text": "",
      "subsections": {
        "Combative_patient": {
          "text": "5-10mg IV\n10mg IM",
          "tables": []
        },
        "Nausea/vomiting": {
          "text": "0.625-2.5mg IV",
          "tables": []
        },
        "Headache": {
          "text": "2.5mg IV or 2.5-5mg IM",
          "tables": []
        },
        "Pain_(with_or_without_opiate_tolerance)": {
          "text": "0.625-5mg or higher IV/IM\n[1]\n[2]",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Combative_patient": {
      "text": "5-10mg IV\n10mg IM",
      "subsections": {
        "Nausea/vomiting": {
          "text": "0.625-2.5mg IV",
          "tables": []
        },
        "Headache": {
          "text": "2.5mg IV or 2.5-5mg IM",
          "tables": []
        },
        "Pain_(with_or_without_opiate_tolerance)": {
          "text": "0.625-5mg or higher IV/IM\n[1]\n[2]",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Nausea/vomiting": {
      "text": "0.625-2.5mg IV",
      "subsections": {
        "Headache": {
          "text": "2.5mg IV or 2.5-5mg IM",
          "tables": []
        },
        "Pain_(with_or_without_opiate_tolerance)": {
          "text": "0.625-5mg or higher IV/IM\n[1]\n[2]",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Headache": {
      "text": "2.5mg IV or 2.5-5mg IM",
      "subsections": {
        "Pain_(with_or_without_opiate_tolerance)": {
          "text": "0.625-5mg or higher IV/IM\n[1]\n[2]",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Pediatric_Dosing": {
      "text": "",
      "subsections": {
        "Nausea/vomiting_2": {
          "text": "2-12yo: 0.015-0.1mg/kg IV/IM",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Nausea/vomiting_2": {
      "text": "2-12yo: 0.015-0.1mg/kg IV/IM",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Special_Populations": {
      "text": "Pregnancy Rating\n: C\nLactation risk: Infant risk cannot be ruled out\nRenal dosing: Administer with caution\nHepatic dosing: Administer with caution",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "Pregnancy Rating",
          "url": "https://wikem.org/wiki/Drug_pregnancy_categories"
        }
      ]
    },
    "Contraindications": {
      "text": "Allergy to class/drug\nKnown or suspected prolonged QT",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Adverse_Reactions": {
      "text": "",
      "subsections": {
        "Serious": {
          "text": "Prolonged QT\n,\ntorsades\n,\nventricular tachycardia\n,\ncardiac arrest\nNote: effect on QT interval is dose-dependent\nIn 2001, FDA gave black box warning for risk of\ntorsades de pointes\n, however there was little evidence to support this\nLarge cohort of patients in ED showed safety of its administration\n[3]\nNeuroleptic malignant syndrome\nAnaphylaxis",
          "tables": []
        },
        "Common": {
          "text": "Somnolence, dysphoria, anxiety\nAkathisia\nHypotension\nTachycardia",
          "tables": []
        }
      },
      "tables": [],
      "links": [
        {
          "text": "Prolonged QT",
          "url": "https://wikem.org/wiki/Prolonged_QT"
        },
        {
          "text": "torsades",
          "url": "https://wikem.org/wiki/Torsades"
        },
        {
          "text": "ventricular tachycardia",
          "url": "https://wikem.org/wiki/Ventricular_tachycardia"
        },
        {
          "text": "cardiac arrest",
          "url": "https://wikem.org/wiki/Cardiac_arrest"
        },
        {
          "text": "torsades de pointes",
          "url": "https://wikem.org/wiki/Torsades_de_pointes"
        },
        {
          "text": "Neuroleptic malignant syndrome",
          "url": "https://wikem.org/wiki/Neuroleptic_malignant_syndrome"
        },
        {
          "text": "Anaphylaxis",
          "url": "https://wikem.org/wiki/Anaphylaxis"
        },
        {
          "text": "Akathisia",
          "url": "https://wikem.org/wiki/Akathisia"
        }
      ]
    },
    "Serious": {
      "text": "Prolonged QT\n,\ntorsades\n,\nventricular tachycardia\n,\ncardiac arrest\nNote: effect on QT interval is dose-dependent\nIn 2001, FDA gave black box warning for risk of\ntorsades de pointes\n, however there was little evidence to support this\nLarge cohort of patients in ED showed safety of its administration\n[3]\nNeuroleptic malignant syndrome\nAnaphylaxis",
      "subsections": {
        "Common": {
          "text": "Somnolence, dysphoria, anxiety\nAkathisia\nHypotension\nTachycardia",
          "tables": []
        }
      },
      "tables": [],
      "links": [
        {
          "text": "Prolonged QT",
          "url": "https://wikem.org/wiki/Prolonged_QT"
        },
        {
          "text": "torsades",
          "url": "https://wikem.org/wiki/Torsades"
        },
        {
          "text": "ventricular tachycardia",
          "url": "https://wikem.org/wiki/Ventricular_tachycardia"
        },
        {
          "text": "cardiac arrest",
          "url": "https://wikem.org/wiki/Cardiac_arrest"
        },
        {
          "text": "torsades de pointes",
          "url": "https://wikem.org/wiki/Torsades_de_pointes"
        },
        {
          "text": "Neuroleptic malignant syndrome",
          "url": "https://wikem.org/wiki/Neuroleptic_malignant_syndrome"
        },
        {
          "text": "Anaphylaxis",
          "url": "https://wikem.org/wiki/Anaphylaxis"
        },
        {
          "text": "Akathisia",
          "url": "https://wikem.org/wiki/Akathisia"
        }
      ]
    },
    "Common": {
      "text": "Somnolence, dysphoria, anxiety\nAkathisia\nHypotension\nTachycardia",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "Akathisia",
          "url": "https://wikem.org/wiki/Akathisia"
        }
      ]
    },
    "Pharmacology": {
      "text": "Half-life: 123-147m (adults), 75-127m (children)\nMetabolism: hepatic\nExcretion: mostly renal",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Mechanism_of_Action": {
      "text": "Dopamine (D2) antagonist. Some serotonergic, histaminergic, and α-adrenergic effect",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "See_Also": {
      "text": "Antipsychotics\nCombative patient",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "Antipsychotics",
          "url": "https://wikem.org/wiki/Antipsychotics"
        },
        {
          "text": "Combative patient",
          "url": "https://wikem.org/wiki/Combative_patient"
        }
      ]
    },
    "External_Links": {
      "text": "emDOCs: Droperidol Use in the Emergency Department – What’s Old is New Again\nACEP: Oldie but a Goodie: 10 Pearls of Droperidol",
      "subsections": {},
      "tables": [],
      "links": []
    }
  }
}